EcoDrugPlus

Diacylglycerol O-Acyltransferase 1

Ensembl ID : ENSONIG00000006003
Gene Symbol: LOC100691118
3 Cross references
189 Possible Orthologues:

Diacylglycerol O-Acyltransferase 1

Ensembl ID : ENSONIG00000002849
Gene Symbol: LOC100691083
3 Cross references
190 Possible Orthologues:

Dihydroorotate Dehydrogenase (Quinone)

Ensembl ID : ENSONIG00000003006
Gene Symbol: DHODH
3 Cross references
172 Possible Orthologues:

Dihydropyrimidine Dehydrogenase

Ensembl ID : ENSONIG00000016599
Gene Symbol: DPYD
3 Cross references
211 Possible Orthologues:

Discoidin Domain Receptor Tyrosine Kinase 2

Ensembl ID : ENSONIG00000002591
Gene Symbol: DDR2
1 Cross references
204 Possible Orthologues:

Discoidin Domain-Containing Receptor 2

Ensembl ID : ENSONIG00000018591
Gene Symbol: LOC100708378
3 Cross references
190 Possible Orthologues:

Disintegrin And Metalloproteinase Domain-Containing Protein 17

Ensembl ID : ENSONIG00000003714
Gene Symbol: LOC100700935
3 Cross references
208 Possible Orthologues:

Dopamine Receptor D2

Ensembl ID : ENSONIG00000006162
Gene Symbol: DRD2
3 Cross references
208 Possible Orthologues:

Dopamine Receptor D3

Ensembl ID : ENSONIG00000014071
Gene Symbol: DRD3
4 Cross references
203 Possible Orthologues:

Dopamine Receptor D5

Ensembl ID : ENSONIG00000009021
Gene Symbol: DRD5
1 Cross references
144 Possible Orthologues:

Dopamine Receptor D5

Ensembl ID : ENSONIG00000020812
Gene Symbol: DRD5
3 Cross references
222 Possible Orthologues:

Ectonucleotide Pyrophosphatase/phosphodiesterase 2

Ensembl ID : ENSONIG00000007198
Gene Symbol: ENPP2
3 Cross references
226 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).